XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.10.0.1

EQUITY-BASED COMPENSATION | 6 Months Ended
--- | ---
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
EQUITY-BASED COMPENSATION | EQUITY-BASED COMPENSATION Our currently outstanding equity-based awards were issued under the Equity Plan which provides for the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, and other equity-based awards or incentive awards. Stock options granted may be either incentive stock options or non-qualified stock options. Vesting terms may vary with each grant, and stock option terms are generally five to ten years. We have outstanding equity-based awards in the form of stock options and restricted stock awards. All of our outstanding equity-based awards are classified as equity awards. The Company's former Chief Financial Officer retired on March 31, 2018. In connection with his retirement, the Company recorded $1.0 million of additional stock-based compensation expense during the six months ended June 30, 2018 related to the modification of certain stock award agreements. Stock Options Granted Under our Equity Plan As of June 30, 2018, we had 235,000 outstanding and exercisable stock options with a weighted average exercise price of $9.75 per share, weighted average contractual term of 2.7 years and an aggregate intrinsic value of $1.1 million. Time-Based Restricted Stock Awards Made Pursuant to Our Equity Plan On March 7, 2018, we granted time-based restricted stock awards for 23,363 shares of common stock to certain of our non-executive employees. The awards vest over a four-year period based on continued service (20% on March 9, 2019, 2020 and 2021, and 40% on March 9, 2022). On March 7, 2018, we granted time-based restricted stock awards for 162,202 shares of common stock to our executive officers. The awards vest 25% on March 9, 2019, 25% on March 9, 2020 and 50% on March 9, 2021, based on continuous service through the vesting dates or in certain circumstances upon a change in control. On March 6, 2017, we granted time-based restricted stock awards for 16,079 shares of common stock to certain of our non-executive employees. The awards vest over a four-year period based on continued service (20% on March 9, 2018, 2019 and 2020, and 40% on March 9, 2021). On March 6, 2017, we granted time-based restricted stock awards for 120,024 shares of common stock to our executive officers. On April 18, 2017, we granted a time-based restricted stock award for 20,215 shares of common stock to an executive officer. The awards vest 25% on March 9, 2018, 25% on March 9, 2019 and 50% on March 9, 2020, based on continuous service through the vesting dates or in certain circumstances upon a change in control. The holders of these awards have the right to vote the related shares of common stock and receive all dividends declared and paid whether or not vested. The fair value of time-based restricted stock awards granted is calculated based on the market value of our common stock on the date of grant. The following table summarizes time-based restricted stock award activity under our Equity Plan for the six months ended June 30, 2018:
|  | Number of Shares |  | Weighted Average Grant Date Fair Value |  | Aggregate Current Value
|  |  |  | (per share) |  | (in thousands)
Non-vested at December 31, 2017 |  | 391,477 |  |  | $ | 13.52 |  |  | $ | 5,962 |
Granted |  | 185,565 |  |  | 13.15 |  |  |  |
Vested |  | (205,619 | ) |  | 13.41 |  |  |  |
Forfeited |  | (818 | ) |  | 12.84 |  |  |  |
Non-vested at June 30, 2018 |  | 370,605 |  |  | $ | 13.40 |  |  | $ | 5,303 |
Performance-Based Restricted Stock Awards Made Pursuant to Our Equity Plan On March 7, 2018, we granted performance-based restricted stock awards for 243,303 shares of common stock to our executive officers. Our performance-based restricted stock awards are market-based awards and are accounted for based on the fair value of our common stock on the grant date. The fair value of the performance-based restricted stock awards granted was estimated using a Monte Carlo simulation valuation model. These awards generally vest based on our percentile ranking within the SNL U.S. REIT Hotel Index at the end of the period beginning on March 7, 2018 and ending on the earlier of March 7, 2021 or upon a change in control. The awards require continued service during the measurement period and are subject to the other conditions described in the Equity Plan or award document. On March 6, 2017, we granted performance-based restricted stock awards for 180,039 shares of common stock to our executive officers. On April 18, 2017, we granted a performance-based restricted stock award for 30,322 shares of common stock to an executive officer. Our performance-based restricted stock awards are market-based awards and are accounted for based on the fair value of our common stock on the grant date. The fair value of the performance-based restricted stock awards granted was estimated using a Monte Carlo simulation valuation model. These awards generally vest based on our percentile ranking within the SNL U.S. REIT Hotel Index at the end of the period beginning on March 6, 2017 and ending on the earlier of March 6, 2020 or upon a change in control. The awards require continued service during the measurement period and are subject to the other conditions described in the Equity Plan or award document. The number of shares the executive officers may earn under these awards range from zero shares to twice the number of shares granted based on our percentile ranking within the index at the end of the measurement period. In addition, a portion of the performance-based shares may be earned based on the Company's absolute total shareholder return calculated during the performance period. The holders of these grants have the right to vote the granted shares of common stock and any dividends declared will be accumulated and will be subject to the same vesting conditions as the awards. Further, if additional shares are earned based on our percentile ranking within the index, dividend payments will be issued as if the additional shares had been held throughout the measurement period. The following table summarizes performance-based restricted stock activity under the Equity Plan for the six months ended June 30, 2018:
|  | Number of Shares |  | Weighted Average Grant Date Fair Value (1) |  | Aggregate Current Value
|  |  |  | (per share) |  | (in thousands)
Non-vested at December 31, 2017 |  | 619,429 |  |  | $ | 16.16 |  |  | $ | 9,434 |
Granted |  | 397,808 |  |  | 15.69 |  |  |  |
Vested |  | (309,010 | ) |  | 18.78 |  |  |  |
Non-vested at June 30, 2018 |  | 708,227 |  |  | $ | 14.75 |  |  | $ | 10,135 |
(1) The amounts included in this column represent the expected future value of the performance-based restricted stock awards calculated using the Monte Carlo simulation valuation model. Director Stock Awards Made Pursuant to Our Equity Plan Our non-employee directors have the option to receive shares of our common stock in lieu of cash for their director fees. During the six months ended June 30, 2018, we issued 2,299 shares of common stock for director fees and we made an annual grant of 34,130 shares of common stock to our independent directors. The fair value of director stock awards is calculated based on the market value of our common stock on the date of grant. Equity-Based Compensation Expense Equity-based compensation expense included in Corporate general and administrative expenses in the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 was as follows (in thousands):
|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
|  | 2018 |  | 2017 |  | 2018 |  | 2017
Time-based restricted stock |  | $ | 516 |  |  | $ | 590 |  |  | $ | 1,352 |  |  | $ | 1,066 |
Performance-based restricted stock |  | 785 |  |  | 850 |  |  | 2,159 |  |  | 1,484 |
Director stock |  | 520 |  |  | 424 |  |  | 537 |  |  | 444 |
|  | $ | 1,821 |  |  | $ | 1,864 |  |  | $ | 4,048 |  |  | $ | 2,994 |
We recognize equity-based compensation expense ratably over the vesting periods. The amount of expense may be subject to adjustment in future periods due to a change in the forfeiture assumptions. Unrecognized equity-based compensation expense for all non-vested awards pursuant to our Equity Plan was $9.2 million at June 30, 2018 and will be recorded as follows (in thousands):
|  | Total |  | 2018 |  | 2019 |  | 2020 |  | 2021 |  | 2022
Time-based restricted stock |  | $ | 3,822 |  |  | $ | 1,035 |  |  | $ | 1,615 |  |  | $ | 956 |  |  | $ | 203 |  |  | $ | 13 |
Performance-based restricted stock |  | 5,361 |  |  | 1,568 |  |  | 2,320 |  |  | 1,287 |  |  | 186 |  |  | — |
|  | $ | 9,183 |  |  | $ | 2,603 |  |  | $ | 3,935 |  |  | $ | 2,243 |  |  | $ | 389 |  |  | $ | 13 |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration